Published on
Dec 2, 2025
Shorter ADT Courses Might Reduce Risks While Still Controlling Prostate Cancer
Los Angeles—Most of the benefits of androgen deprivation therapy (ADT) for prostate cancer treated with radiotherapy accrue within the first 9 to 12 months, according to a new study. The University of California, Los Angeles (UCLA)–led authors caution that …
Source:
U.S. Pharmacist - New Jersey
-
Neutral
:max_bytes(150000):strip_icc()/Health-GettyImages-468382854-591fc460626b47b8b4bcf913fab6ec85.jpg)
